Delivery Order SPE2DX22D0010-SPE2D825FCH97
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$11K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,053.70 Firm Fixed Price Delivery Order is for the supply of VYVANSE CAPS 70MG, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FDL11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $46,752.89 firm-fixed-price delivery order is for the supply of VYVANSE CAPS 30MG, a pharmaceutical product, with a completion date of February 12, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $50,604.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award, SPE2DX22D0010|SPE2D825FDG96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,667.05 firm fixed-price delivery order is for the supply of 40mg VYVANSE capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of February 6, 2025. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FCS78, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $10,280.91 firm fixed-price delivery order is for the provision of VYVANSE CAPS 40MG, a pharmaceutical product, with a period of performance through January 16, 2025. The award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,110.55 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,570.62 Firm Fixed Price Delivery Order contract is for the supply of VYVANSE CAPS 70MG, a prescription medication. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,495.11 firm fixed-price delivery order is for the supply of 4566477213 VYVANSE 40 MG CAPSULE 100S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.04 firm fixed-price delivery order is for the supply of 4567059430 - VYVANSE 30 MG CAPSULE 100S, with a period of performance through January 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.78 firm fixed-price delivery order is for the supply of VYVANSE 60 MG CAPSULE 100S to support federal healthcare programs. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...